Teucrium polium reversed the MCD diet-induced liver injury in rats
- 5 November 2010
- journal article
- Published by SAGE Publications in Human & Experimental Toxicology
- Vol. 30 (9), 1303-1312
- https://doi.org/10.1177/0960327110388961
Abstract
In the present study, we evaluated the ability of Teucrium polium ethyl acetate fraction, with high antioxidant activity, in the treatment of nonalcoholic steatohepatitis (NASH) in rats and its possible effect on factors involved in pathogenesis of the disease. To induce NASH, a methionine and choline deficient (MCD) diet was given to N-Mary rats for 8 weeks. After NASH development, MCD-fed rats were divided into 2 groups: NASH group that received MCD diet and NASH + T group which was fed MCD diet plus ethyl acetate fraction of T. polium orally for 3 weeks. Histopathological evaluations revealed that treatment with the extract has abated the severity of NASH among the MCD-fed rats. In addition, the fraction reduced the elevated levels of hepatic tumor necrosis factor-alpha (TNF-α) and transforming growth factor-beta (TGF-β) gene expression and also the elevated level of malondialdehyde (MDA). In addition, the extract increased the activities of superoxide dismutase (SOD), glutathione peroxidase (GPx) and enhanced the level of hepatic glutathione (GSH). Moreover, the fraction treatments lowered caspase-3 level and the phosphorylated form of C-Jun N-terminal kinase (JNK) and augmented the phosphrylated level of extracellular regulated kinase1/2 (ERK1/2). These results indicate that the ethyl acetate fraction of T. poium effectively reversed NASH, mainly due to its strong antioxidant and anti-inflammatory properties.Keywords
This publication has 33 references indexed in Scilit:
- Molecular basis and mechanisms of progression of non-alcoholic steatohepatitisTrends in Molecular Medicine, 2008
- Non-alcoholic steatohepatitis: From cell biology to clinical practiceJournal of Hepatology, 2006
- Jnk1 but not jnk2 promotes the development of steatohepatitis in miceJournal of Hepatology, 2005
- Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis PatientsThe American Journal of Gastroenterology, 2004
- Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitisGastroenterology, 2003
- Nonalcoholic Fatty Liver DiseaseThe New England Journal of Medicine, 2002
- Gene expression of tumor necrosis factor [alpha ] and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patientsJournal of Hepatology, 2001
- Transforming growth factor β and the liverJournal of Hepatology, 2001
- Mammalian Mitogen-Activated Protein Kinase Signal Transduction Pathways Activated by Stress and InflammationPhysiological Reviews, 2001
- Cytokines in Alcoholic and Nonalcoholic SteatohepatitisThe New England Journal of Medicine, 2000